VMAT

RADIATION3 trials

Sponsors

British Columbia Cancer Agency, Chinese Academy of Medical Sciences, Eye & ENT Hospital of Fudan University

Conditions

Nasopharyngeal CarcinomaNeoplasm MetastasisNeoplasmsNeoplastic ProcessesORROSPFSPathologic Processes

Phase 2

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

Chinese Academy of Medical SciencesNasopharyngeal Carcinoma

Start: 2019-05-01End: 2022-05-01Target: 47Updated: 2021-01-29

Unknown Phase

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

TerminatedNCT03694015

British Columbia Cancer AgencyNeoplasm Metastasis, Neoplasms, Neoplastic Processes +1

Start: 2019-12-02End: 2026-02-27Updated: 2026-03-11

A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma

Enrolling by invitationNCT07449949

Eye & ENT Hospital of Fudan UniversityORR, OS, PFS

Start: 2025-10-30End: 2030-12-30Target: 43Updated: 2026-03-04

Related Papers

SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol

BMC Cancer2019-10-2814 citations